Search ( 3951 results )
- article
(Updated on )
Should a multiparametric MRI be performed before every prostate biopsy?
The role of multiparametric MRI (mpMRI) in the management of prostate cancer is undergoing significant change. While it continues to play a (limited) role in assessing local disease...
- article
(Updated on )
Genitourinary infections and the risk of prostate cancer: the EPICAP study.
Introduction: Genitourinary infections, including prostatitis, are thought to increase the risk of prostate cancer due to the chronic inflammation they may cause. We investigated the...
- article
(Updated on )
QALIPRO: Long-term quality of life in patients treated for localized prostate cancer. A general population study.
Introduction: Given the increasing number of patients surviving long-term after prostate cancer and the range of treatment options, all of which may lead to side effects, this study...
- article
(Updated on )
Prostate Cancer in the French West Indies: An Overview.
In the French West Indies, prostate cancer is the most common type of cancer, accounting for more than 50% of new cases among men. Its incidence and mortality rates are higher there than...
- article
(Updated on )
Sickle Cell Disease in France: Epidemiological Data to Improve Care [Editorial]
- article
(Updated on )
Neonatal screening for sickle cell disease in France.
Sickle cell disease, which is still poorly understood by clinicians, is now the most common genetic disorder in France. Screening and diagnosis performed at birth, targeting at-risk...
- article
(Updated on )
Descriptive studies of mortality and hospitalizations related to sickle cell disease in France.
Introduction. As part of the 2005–2008 and 2011–2014 National Plans for Rare Diseases, the databases of the Center for Epidemiology on Medical Causes of Death (CépiDc) and hospital stays...
- article
(Updated on )
Sidebar. Rofsed, a healthcare network dedicated to the management of sickle cell disease in children.
- article
(Updated on )
Sickle Cell Disease and Blood Transfusion: The Policy of the French Blood Establishment.
Transfusion therapy remains a key component of the treatment of sickle cell disease. Given that blood groups vary depending on an individual’s geographic origin, transfusion therapy can...
- article
(Updated on )
Sickle cell disease. Current trends in genetic counseling in France.
Major sickle cell disease (primarily affecting SS, SC, and SB° individuals) is a major public health issue in France due to its high incidence: more than 400 newborns with this genetic...
